Home > Insider Trading > Filing (0000899243-20-008492)

Filing Details

Accession Number:: 0000899243-20-008492
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-16 17:15:42
Reporting Period:: 2020-03-16

Accepted Time:: 2020-03-16 17:15:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1672619	Imara Inc.	IMRA	Pharmaceutical Preparations (2834)	811523849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1722234	Kirstine Mette Agger	Scherfigsvej 7, Dk-2100 Copenhagen G7		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-16	1,245,222	$0.00	1,245,222	No	4	C	Indirect	By Lundbeckfond Invest A/S
Common Stock	Acquisiton	2020-03-16	187,500	$16.00	1,432,722	No	4	P	Indirect	By Lundbeckfond Invest A/S

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Lundbeckfond Invest A/S
No	4	P	Indirect	By Lundbeckfond Invest A/S

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Preferred Stock	Disposition	2020-03-16	478,749	$0.00	76,003	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-03-16	5,470,492	$0.00	868,467	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-03-16	1,894,444	$0.00	300,752	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2020-03-16	15,457	$0.00	15,457	$16.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
15,457	2030-03-15	No	4	A	Direct

Footnotes

On March 16, 2020, the Series Seed Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
On March 16, 2020, Series A Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
On March 16, 2020, the Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The reporting person is a managing partner at Lundbeckfonden Ventures, an affiliate of Lundbeckfond Invest A/S. The reporting person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.
The option vests in three equal installments on March 16, 2021, 2022 and 2023.